Corrigendum to “Inhibition of HIV-1 replication using the CRISPR/noNLS-Cas9 system as a prophylactic strategy” <[Heliyon 8 (9) (2022) e10483]>

por Salimi-Jeda, Ali, Esghaei, Maryam, keyvani, Hossein, Bokharaei-Salim, Farah, Teimoori, Ali, Abdoli, Asghar
Publicado 2022

Inhibition of HIV-1 replication using the CRISPR/cas9-no NLS system as a prophylactic strategy

por Salimi-Jeda, Ali, Esghaei, Maryam, Hossein keyvani, Bokharaei-Salim, Farah, Teimoori, Ali, Abdoli, Asghar
Publicado 2022

SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies

por Salimi-Jeda, Ali, Abbassi, Sina, Mousavizadeh, Atieh, Esghaie, Maryam, Bokharaei-Salim, Farah, Jeddi, Farhad, Shafaati, Maryam, Abdoli, Asghar
Publicado 2021